| DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Wood Todd Michael | Chief Commercial Officer | Jun 08 | Sale | 43.43 | 425 | 18,458 | 152,519 | Jun 10 08:19 PM | | Sun Kevin M | Chief Financial Officer | Jun 08 | Sale | 43.43 | 2,870 | 124,644 | 156,411 | Jun 10 08:18 PM | | Ibarra Claudia | Chief Operating Officer | Jun 08 | Sale | 43.43 | 2,405 | 104,449 | 118,510 | Jun 10 08:17 PM | | Dobak John | Chief Executive Officer | Jun 08 | Sale | 43.43 | 1,118 | 48,555 | 476,498 | Jun 10 08:16 PM | | Dobak John | Chief Executive Officer | Jun 02 | Sale | 40.00 | 9,530 | 381,200 | 477,616 | Jun 03 08:19 PM | | Dobak John | Chief Executive Officer | Jun 01 | Sale | 40.22 | 2,970 | 119,443 | 487,146 | Jun 03 08:19 PM | | Picozza Enrico | Director | May 26 | Sale | 40.08 | 20,297 | 813,577 | 500,000 | May 28 08:18 PM | | Picozza Enrico | Director | May 25 | Sale | 40.01 | 4,703 | 188,158 | 520,297 | May 25 06:43 PM | | Wood Todd Michael | Chief Commercial Officer | May 25 | Sale | 40.00 | 10,000 | 400,000 | 152,944 | May 27 08:08 PM | | Picozza Enrico | Director | May 21 | Sale | 37.40 | 25,000 | 935,045 | 525,000 | May 25 06:43 PM | | Picozza Enrico | Director | May 20 | Sale | 36.73 | 94,719 | 3,478,803 | 550,000 | May 20 08:16 PM | | Picozza Enrico | Director | May 19 | Sale | 35.66 | 140,017 | 4,993,130 | 644,719 | May 20 08:16 PM | | Picozza Enrico | Director | May 18 | Sale | 37.42 | 21,126 | 790,510 | 784,736 | May 20 08:16 PM | | Dobak John | Chief Executive Officer | May 03 | Sale | 40.96 | 25,000 | 1,023,930 | 490,116 | May 05 04:19 PM | | Dobak John | Chief Executive Officer | Apr 27 | Sale | 51.35 | 25,000 | 1,283,750 | 515,116 | Apr 29 04:04 PM | | Jacobs Gary E. | Director | Apr 19 | Option Exercise | 1.10 | 21,843 | 24,117 | 547,438 | Apr 21 04:46 PM | | Wood Todd Michael | Chief Commercial Officer | Apr 12 | Sale | 46.33 | 10,000 | 463,321 | 162,944 | Apr 14 05:01 PM | | Dobak John | Chief Executive Officer | Apr 12 | Sale | 46.34 | 25,000 | 1,158,500 | 540,116 | Apr 14 04:59 PM | | Wood Todd Michael | Chief Commercial Officer | Mar 08 | Sale | 50.04 | 417 | 20,867 | 164,782 | Mar 10 05:18 PM | | Sun Kevin M | Chief Financial Officer | Mar 08 | Sale | 50.04 | 2,886 | 144,415 | 151,261 | Mar 10 05:14 PM | | Ibarra Claudia | Chief Operating Officer | Mar 08 | Sale | 50.04 | 2,431 | 121,647 | 114,930 | Mar 10 05:11 PM | | Dobak John | Chief Executive Officer | Mar 08 | Sale | 50.04 | 780 | 39,031 | 543,071 | Mar 10 05:09 PM | | Jansen Burkhard | Chief Medical Officer | Jan 26 | Option Exercise | 6.94 | 5,000 | 34,700 | 79,037 | Jan 28 06:19 PM | | Posard Matthew L. | Director | Jan 11 | Buy | 29.50 | 33,898 | 999,991 | 86,863 | Jan 13 04:21 PM | | RTW INVESTMENTS, LP | 10% Owner | Jan 07 | Buy | 29.50 | 200,000 | 5,900,000 | 3,087,216 | Jan 11 06:04 PM | | PANCOAST SCOTT R | Director | Dec 14 | Sale | 13.93 | 6,000 | 83,569 | 44,132 | Dec 16 04:40 PM | | Jansen Burkhard | Chief Medical Officer | Dec 14 | Sale | 12.41 | 5,000 | 62,050 | 79,037 | Dec 16 04:36 PM | | Jansen Burkhard | Chief Medical Officer | Dec 11 | Sale | 12.20 | 5,000 | 61,000 | 74,037 | Dec 17 08:11 PM | | Wood Todd Michael | Chief Commercial Officer | Dec 08 | Sale | 11.86 | 428 | 5,076 | 165,199 | Dec 10 04:10 PM | | Ibarra Claudia | Chief Operating Officer | Dec 08 | Sale | 11.86 | 2,421 | 28,713 | 115,246 | Dec 10 04:08 PM | | Dobak John | Chief Executive Officer | Dec 08 | Sale | 11.86 | 786 | 9,322 | 541,683 | Dec 10 04:06 PM | | PANCOAST SCOTT R | Director | Dec 07 | Sale | 12.00 | 2,382 | 28,584 | 50,132 | Dec 09 04:44 PM | | Jacobs Gary E. | Director | Oct 26 | Option Exercise | 1.08 | 692 | 747 | 523,903 | Oct 28 04:11 PM | | Wood Todd Michael | Chief Commercial Officer | Sep 10 | Sale | 10.82 | 1,345 | 14,558 | 165,627 | Sep 14 07:38 PM | | Dobak John | Chief Executive Officer | Sep 10 | Sale | 10.82 | 2,470 | 26,735 | 542,469 | Sep 14 07:36 PM | | Ibarra Claudia | Chief Operating Officer | Sep 10 | Sale | 10.82 | 7,605 | 82,316 | 117,667 | Sep 14 07:34 PM |
|
